SCHEMBL526255

SCHEMBL526255

NC(=S)Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.67
MAPT P10636 4/20 0.67
ALDH1A1 P00352 3/20 0.67
IDO1 P14902 2/20 0.67
GLA P06280 1/20 0.67
EPHX1 P07099 2/20 0.59
EPHX2 P34913 2/20 0.59
LMNA P02545 5/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
POLB P06746 1/20 0.54
CA2 P00918 1/20 0.53
CA4 P22748 1/20 0.53
CA5A P35218 1/20 0.53
CA9 Q16790 1/20 0.53
CDK1 P06493 1/20 0.53
NPC1 O15118 2/20 0.52
KDM4E B2RXH2 1/20 0.52
PKM P14618 1/20 0.52
RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29838484 1.00 GAA (0.67) GAAMAPTALDH1A1IDO1GLA
SCHEMBL8296719 0.83 IDO1 (0.61) GAAMAPTALDH1A1IDO1GLA
SCHEMBL4555003 0.83 IDO1 (0.78) GAAMAPTALDH1A1IDO1EPHX1
SCHEMBL3299680 0.82 KMT2A (0.73) GAAMAPTALDH1A1LMNAMEN1
SCHEMBL68180 0.82 MAPT (0.70) GAAMAPTALDH1A1MEN1KMT2A
SCHEMBL10592427 0.82 CYP1A2 (0.53) GAAMAPTALDH1A1IDO1GLA
SCHEMBL7308178 0.81 IDO1 (0.63) GAAMAPTALDH1A1IDO1GLA
SCHEMBL238488 0.80 GAA (1.00) GAAMAPTALDH1A1IDO1GLA
SCHEMBL5988806 0.80 IDO1 (1.00) GAAMAPTALDH1A1IDO1EPHX1
SCHEMBL29352610 0.79 EPHX1 (0.70) GAAMAPTALDH1A1IDO1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462459-B Low-sensitization epoxy resin curing agent and preparation method thereof 安徽美东生物材料有限公司 2025-05-06 CN claimed
CN-116024136-B Burkholderia vietnamensis and application thereof in treatment of dye wastewater containing 3, 4-dichlorophenyl thiourea 常州大学 2025-04-01 CN claimed
CN-119462459-A Low-sensitization epoxy resin curing agent and preparation method thereof 安徽美东生物材料有限公司 2025-02-18 CN claimed
CN-115448863-B Continuous preparation process of 3, 4-dichlorophenyl thiourea 浙江迪邦化工有限公司 2024-03-26 CN claimed
CN-115466177-B Method for preparing 1, 4-diacetoxy-2-butene 中国科学院大连化学物理研究所 2024-02-02 CN claimed
CN-116024136-A Burkholderia vietnamensis and application thereof in treatment of dye wastewater containing 3, 4-dichlorophenyl thiourea 常州大学 2023-04-28 CN claimed
CN-114432901-B Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof 中国石油化工股份有限公司 2023-04-11 CN claimed
WO-2022257025-A1 MONATOMICALLY DISPERSED PALLADIUM-BASED CATALYST, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 中国科学院大连化学物理研究所 2022-12-15 WO claimed
CN-115466177-A Method for preparing 1, 4-diacetyloxy-2-butene 中国科学院大连化学物理研究所 2022-12-13 CN claimed
CN-115445636-A Monoatomic dispersed palladium-based catalyst, and preparation method and application thereof 中国科学院大连化学物理研究所 2022-12-09 CN claimed
CN-115448863-A Continuous preparation process of 3, 4-dichlorophenyl thiourea 浙江迪邦化工有限公司 2022-12-09 CN claimed
WO-2022105199-A1 PALLADIUM-BASED CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院大连化学物理研究所 2022-05-27 WO claimed
CN-114432901-A Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof 中国石油化工股份有限公司 2022-05-06 CN claimed
CN-105503678-A Clean production method of 1-(3,4-dichlorophenyl)-2-thiourea JIANGSU YUANZHENG CHEMICAL CO LTD 2016-04-20 CN claimed
US-7897720-B2 Method for removing catalyst residues from polymer solution and polymers purified by the method LG CHEM, LTD. (KR) 2011-03-01 US claimed
US-20100029900-A1 METHOD FOR REMOVING CATALYST RESIDUES FROM POLYMER SOLUTION AND POLYMERS PURIFIED BY THE METHOD LG CHEM, LTD. (KR) 2010-02-04 US claimed
WO-2008056938-A1 METHOD FOR REMOVING CATALYST RESIDUES FROM POLYMER SOLUTION AND POLYMERS PURIFIED BY THE METHOD LG CHEM, LTD. (KR) 2008-05-15 WO claimed
EP-1339668-A2 BISUBSTITUTED CARBOCYCLIC CYCLOPHILIN BINDING COMPOUNDS AND THEIRUS GUILFORD PHARMACEUTICALS INC. (US) 2003-09-03 EP claimed
WO-2002044126-A2 BISUBSTITUTED CARBOCYCLIC CYCLOPHILIN BINDING COMPOUNDS AND THEIRUS GUILFORD PHARMACEUTICALS INC. (US) 2002-06-06 WO claimed
CN-119462459-B Low-sensitization epoxy resin curing agent and preparation method thereof 安徽美东生物材料有限公司 2025-05-06 CN disclosed
CN-116024136-B Burkholderia vietnamensis and application thereof in treatment of dye wastewater containing 3, 4-dichlorophenyl thiourea 常州大学 2025-04-01 CN disclosed
CN-116024136-B Burkholderia vietnamensis and application thereof in treatment of dye wastewater containing 3, 4-dichlorophenyl thiourea 常州大学 2025-04-01 CN disclosed
CN-119462459-A Low-sensitization epoxy resin curing agent and preparation method thereof 安徽美东生物材料有限公司 2025-02-18 CN disclosed
US-20240390333-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2024-11-28 US disclosed
US-11974988-B2 Neuroprotective compositions and methods of using the same BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2024-05-07 US disclosed
CN-115448863-B Continuous preparation process of 3, 4-dichlorophenyl thiourea 浙江迪邦化工有限公司 2024-03-26 CN disclosed
CN-115448863-B Continuous preparation process of 3, 4-dichlorophenyl thiourea 浙江迪邦化工有限公司 2024-03-26 CN disclosed
CN-115448863-B Continuous preparation process of 3, 4-dichlorophenyl thiourea 浙江迪邦化工有限公司 2024-03-26 CN disclosed
CN-115466177-B Method for preparing 1, 4-diacetoxy-2-butene 中国科学院大连化学物理研究所 2024-02-02 CN disclosed
CN-115445636-B Monoatomic dispersed palladium-based catalyst and preparation method and application thereof 中国科学院大连化学物理研究所 2023-12-12 CN disclosed
US-20230263167-A1 METHOD OF PREPARING A BISMUTH SULFIDE PARTICLE CONTAINING ANTIBACTERIAL COMPOSITION IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-08-24 US disclosed
US-11700855-B2 Method for preventing or reducing growth of a microorganism on a surface IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-07-18 US disclosed
CN-116024136-A Burkholderia vietnamensis and application thereof in treatment of dye wastewater containing 3, 4-dichlorophenyl thiourea 常州大学 2023-04-28 CN disclosed
CN-116024136-A Burkholderia vietnamensis and application thereof in treatment of dye wastewater containing 3, 4-dichlorophenyl thiourea 常州大学 2023-04-28 CN disclosed
US-20230129765-A1 METHOD FOR PRODUCING POLYTHIOETHER COMPOUND DAICEL CORPORATION (JP) 2023-04-27 US disclosed
CN-114432901-B Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof 中国石油化工股份有限公司 2023-04-11 CN disclosed
CN-115611745-A Method for continuously producing 3, 4-dichloronitrobenzene 浙江闰土股份有限公司 2023-01-17 CN disclosed
EP-4108705-A1 METHOD FOR PRODUCING POLYTHIOETHER COMPOUND Daicel Corporation (JP) 2022-12-28 EP disclosed
WO-2022257025-A1 MONATOMICALLY DISPERSED PALLADIUM-BASED CATALYST, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 中国科学院大连化学物理研究所 2022-12-15 WO disclosed
CN-115466177-A Method for preparing 1, 4-diacetyloxy-2-butene 中国科学院大连化学物理研究所 2022-12-13 CN disclosed
CN-115445636-A Monoatomic dispersed palladium-based catalyst, and preparation method and application thereof 中国科学院大连化学物理研究所 2022-12-09 CN disclosed
CN-115448863-A Continuous preparation process of 3, 4-dichlorophenyl thiourea 浙江迪邦化工有限公司 2022-12-09 CN disclosed
CN-115448863-A Continuous preparation process of 3, 4-dichlorophenyl thiourea 浙江迪邦化工有限公司 2022-12-09 CN disclosed
CN-115448863-A Continuous preparation process of 3, 4-dichlorophenyl thiourea 浙江迪邦化工有限公司 2022-12-09 CN disclosed
CN-115135697-A Process for producing polythioether compound 株式会社大赛璐 2022-09-30 CN disclosed
WO-2022105199-A1 PALLADIUM-BASED CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院大连化学物理研究所 2022-05-27 WO disclosed
CN-114432901-A Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof 中国石油化工股份有限公司 2022-05-06 CN disclosed
CN-113278149-A Process for producing polythioether compound 株式会社大赛璐 2021-08-20 CN disclosed
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2021-07-08 US disclosed
CN-106748810-B Treatment method of disperse dye intermediate 浙江闰土研究院有限公司 2021-04-27 CN disclosed
US-20210061670-A1 METHOD FOR PREVENTING OR REDUCING GROWTH OF A MICROORGANISM ON A SURFACE IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2021-03-04 US disclosed
US-10934176-B2 Methods of degrading organic pollutants and preventing or treating microbe using Bi2S3-CdS particles IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2021-03-02 US disclosed
US-20200102228-A1 METHODS OF DEGRADING ORGANIC POLLUTANTS AND PREVENTING OR TREATING MICROBE USING Bi2S3-CdS PARTICLES IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2020-04-02 US disclosed
CN-107098895-B Benzoylaminothiazolylmethyl quinolinone derivative and preparation method and application thereof 湖南大学 2020-01-07 CN disclosed
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2019-08-20 US disclosed
CN-109971202-A A kind of benzothiazoles dispersion dyes monomer compound and its synthetic method and application 浙江迪邦化工有限公司 2019-07-05 CN disclosed
CN-109651157-A The method for being nitrified using o-dichlorohenzene, hydrogen being added to prepare 3,4- dichloroaniline 杨向党 2019-04-19 CN disclosed
US-10105687-B1 Heterostructured Bi2S3—ZnS photocatalysts and methods thereof IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2018-10-23 US disclosed
US-20180282348-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2018-10-04 US disclosed
CN-107973720-A A kind of method of micro passage reaction synthesis 3,4- dichloroanilines 黑龙江鑫创生物科技开发有限公司 2018-05-01 CN disclosed
CN-107466296-A Imidazo [2,1 b] thiazole and 5,6 glyoxalidine as S100 inhibitor simultaneously [2,1 b] thiazole 活跃生物技术有限公司 2017-12-12 CN disclosed
WO-2017143230-A1 ANTIFUNGAL COMPOUNDS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-08-24 WO disclosed
EP-2700636-B1 PROCESS FOR PREPARING EPISULFIDE COMPOUNDS ASAHI CHEMICAL IND (JP) 2017-08-02 EP disclosed
CN-104059060-B A kind of ketones derivant of 5 (methylene of 1H indoles 3) 1,3 thiazolidine 4 and its synthetic method and application 西安交通大学 2017-08-01 CN disclosed
CN-106748810-A A kind of processing method of disperse dyes intermediate 浙江闰土研究院有限公司 2017-05-31 CN disclosed
EP-2760856-B1 SELECTIVE NR2B ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2016-09-14 EP disclosed
US-9359324-B2 Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-06-07 US disclosed
CN-103476764-B Process for producing episulfide compound ASAHI KASEI KABUSHIKI KAISHA (JP) 2016-05-25 CN disclosed
CN-105503678-A Clean production method of 1-(3,4-dichlorophenyl)-2-thiourea JIANGSU YUANZHENG CHEMICAL CO LTD 2016-04-20 CN disclosed
CN-105503678-A Clean production method of 1-(3,4-dichlorophenyl)-2-thiourea JIANGSU YUANZHENG CHEMICAL CO LTD 2016-04-20 CN disclosed
CN-105503678-A Clean production method of 1-(3,4-dichlorophenyl)-2-thiourea JIANGSU YUANZHENG CHEMICAL CO LTD 2016-04-20 CN disclosed
WO-2016042172-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2016-03-24 WO disclosed
CN-101129295-B There is the binary initiator system of good storage stability and especially suitable for acidic system HERAEUS KULZER GMBH (DE) 2016-02-10 CN disclosed
US-20150197501-A1 Process for Preparing Episulfide Compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-07-16 US disclosed
US-9051293-B2 Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-06-09 US disclosed
CN-104610222-A Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORP 2015-05-13 CN disclosed
CN-104059060-A 5-(1H-indolyl-3-methylene)-1,3-thiazolidinyl-4-one derivatives, and synthesis method and application thereof UNIV XI AN JIAOTONG 2014-09-24 CN disclosed
CN-102603726-B 5-(2-aminothiazole-4-yl) benzofuranol etheric compound with herbicidal activity and preparation method HUNAN RES INST CHEMICAL IND 2014-08-13 CN disclosed
EP-2760856-A1 SELECTIVE NR2B ANTAGONISTS Bristol-Myers Squibb Company (US) 2014-08-06 EP disclosed
US-8722670-B2 Selective NR2B antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2014-05-13 US disclosed
US-20140107350-A1 Process for Preparing Episulfide Compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-04-17 US disclosed
EP-2700636-A1 PROCESS FOR PREPARING EPISULFIDE COMPOUNDS Asahi Kasei Chemicals Corporation (JP) 2014-02-26 EP disclosed
CN-103476764-A Process for producing episulfide compound ASAHI KASEI CHEMICALS CORP (JP) 2013-12-25 CN disclosed
US-8513430-B2 Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators HIGH POINT PHARMACEUTICALS, LLC (US) 2013-08-20 US disclosed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20130085138-A1 Selective NR2B Antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-04 US disclosed
WO-2013049119-A1 SELECTIVE NR2B ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-04 WO disclosed
CN-102070556-B 5-benzyl-4-alkyl-2-aminothiazole as well as preparation and application of 5-benzyl-4-alkyl-2-aminothiazole UNIV HUNAN 2013-03-20 CN disclosed
EP-1686990-B1 2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF US ARMY MED RES MAT COMMAND (US) 2012-09-19 EP disclosed
CN-102603726-A 5-(2-aminothiazole-4-yl) benzofuranol etheric compound with herbicidal activity and preparation method HUNAN RES INST CHEMICAL IND 2012-07-25 CN disclosed
CN-102010406-B 4-(benzofuran-5-yl)-2-aromatic aminothiazole and preparation method and application thereof UNIV HUNAN 2012-07-04 CN disclosed
US-20120029029-A1 SUBSTITUTED THIAZOL-2-YLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS 11-BETA HSD1 MODULATORS HIGH POINT PHARMACEUTICALS, LLC (US) 2012-02-02 US disclosed
WO-2012015715-A1 SUBSTITUTED THIAZOL-2-YLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS 11-BETA HSD1 MODULATORS HIGH POINT PHARMACEUTICALS, LLC (US) 2012-02-02 WO disclosed
CN-102070556-A 5-benzyl-4-alkyl-2-aminothiazole as well as preparation and application of 5-benzyl-4-alkyl-2-aminothiazole UNIV HUNAN 2011-05-25 CN disclosed
US-20110105436-A1 HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT AUCKLAND UNISERVICES LIMITED (NZ) 2011-05-05 US disclosed
CN-102010406-A 4-(benzofuran-5-yl)-2-aromatic aminothiazole and preparation method and application thereof UNIV HUNAN 2011-04-13 CN disclosed
US-7897720-B2 Method for removing catalyst residues from polymer solution and polymers purified by the method LG CHEM, LTD. (KR) 2011-03-01 US disclosed
WO-2010086613-A1 COMPOUNDS USEFUL AS INHIBITORS AS AMPK BETAGENON AB (SE) 2010-08-05 WO disclosed
CN-101768134-A 2-imido-3-(substituted phenyl)-4-methyl-5-acetyl-4-thiazoline and synthesis method thereof ZHEJIANG PHARMACEUTICAL COLLEG 2010-07-07 CN disclosed
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP disclosed
US-20100029900-A1 METHOD FOR REMOVING CATALYST RESIDUES FROM POLYMER SOLUTION AND POLYMERS PURIFIED BY THE METHOD LG CHEM, LTD. (KR) 2010-02-04 US disclosed
WO-2009114552-A1 HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2009-09-17 WO disclosed
EP-1686990-A4 2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF US ARMY MED RES MAT COMMAND (US) 2009-06-03 EP disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed
US-20080200371-A1 THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES IMPINJ, INC. 2008-08-21 US disclosed
WO-2008090356-A1 THIAZOLIDINONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND DISORDERS CAUSED BY EXCESS ADIPOSITY BETAGENON AB (SE) 2008-07-31 WO disclosed
US-7381736-B2 Thiazole and thiadiazole inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. (US) 2008-06-03 US disclosed
WO-2008056938-A1 METHOD FOR REMOVING CATALYST RESIDUES FROM POLYMER SOLUTION AND POLYMERS PURIFIED BY THE METHOD LG CHEM, LTD. (KR) 2008-05-15 WO disclosed
EP-1899335-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2008-03-19 EP disclosed
CN-101129295-A 2-component initiator system (amine free) with storage stability and especially suitable for acidic systems HERAEUS KULZER GMBH (DE) 2008-02-27 CN disclosed
EP-1841749-A1 DERIVATIVES OF THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES Metabasis Therapeutics, Inc. (US) 2007-10-10 EP disclosed
CN-1919832-A Method of preparing arylamine chloride by high selective catalytic hydrogenation of chlorine substituent aromatic nitro compound UNIV DALIAN TECH (CN) 2007-02-28 CN disclosed
US-20070040151-A1 Two-component initiator system (amine-free) with very good storage stability and particular suitability for acid systems HERAEUS KULZER GMBH (DE) 2007-02-22 US disclosed
WO-2007003611-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2007-01-11 WO disclosed
US-7101902-B2 2-guanidinylimidazolidinedione compounds and methods of making and using thereof THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2006-09-05 US disclosed
US-20060194768-A1 Thiazole and thiadiazole inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2006-08-31 US disclosed
EP-1686990-A2 2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF U.S. Army Medical Research and Materiel Command (US) 2006-08-09 EP disclosed
US-20060173096-A1 Aqueous ink composition, and ink jet recording method and recorded matter using the same SEIKO EPSON CORPORATION 2006-08-03 US disclosed
WO-2006028970-A1 DERIVATIVES OF THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES CENGENT THERAPEUTICS, INC. (US) 2006-03-16 WO disclosed
EP-1315714-B1 QUINAZOLINE DERIVATIVES AS ALPHA-1 ADRENERGIC ANTAGONISTS HOFFMANN LA ROCHE (CH) 2005-11-09 EP disclosed
WO-2005072082-A2 2-GUANIDINYLIMIDAZOLIDINEDIONE COMPOUNDS AND METHODS OF MAKING AND USING THEREOF U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND (US) 2005-08-11 WO disclosed
US-20050148645-A1 2-Guanidinylimidazolidinedione compounds and methods of making and using thereof ARMY, UNITED STATES 2005-07-07 US disclosed
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
EP-1315714-A2 QUINAZOLINE DERIVATIVES AS ALPHA-1 ADRENERGIC ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-06-04 EP disclosed
US-6559153-B2 1-(4-(((4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino) methyl)-4-phenyl-piperidin-1-yl)-1-cyclopropyl-methanone; treating disease states ameliorated by blockade of alpha-1 adrenoceptors; sleep/psychological disorders SYNTEX (U.S.A.) LLC 2003-05-06 US disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed
US-20020045614-A1 Quinazoline derivatives as alpha-1 adrenergic antagonists SYNTEX (U.S.A.) LLC 2002-04-18 US disclosed
WO-2002018348-A2 QUINAZOLINE DERIVATIVES AS ALPHA-1 ADRENERGIC ANTAGONISTS F. HOFFMAN-LA ROCHE AG (CH) 2002-03-07 WO disclosed
US-5498502-A POLYCYCLIC QUINONE COMPOUNDS WITH PHTHALOCYANINE DYES FOR PRINTING NIPPON PAINT CO., LTD. (JP) 1996-03-12 US disclosed
EP-0666507-A2 Negative charging type printing photosensitive resin composition Nippon Paint Co., Ltd. (JP) 1995-08-09 EP disclosed
US-5342958-A Insecticides SOLVAY DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1994-08-30 US disclosed
US-5245071-A Insecticides DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1993-09-14 US disclosed
EP-0535184-A1 NOVEL QUINOLONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME BOUCHARA S.A. (FR) 1993-04-07 EP disclosed
EP-0533895-A1 NOVEL QUINOLONES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BOUCHARA S.A. (FR) 1993-03-31 EP disclosed
WO-1992017466-A1 NOVEL QUINOLONES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BOUCHARA S.A. (FR) 1992-10-15 WO disclosed
WO-1992015574-A1 NOVEL QUINOLONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME BOUCHARA S.A. (FR) 1992-09-17 WO disclosed
US-5142064-A Larvicides has benzoyl or thiobenzoyl group DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1992-08-25 US disclosed
US-4833151-A INTERFERES WITH METAMORPHOSES DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1989-05-23 US disclosed
US-4563533-A FROM CORRESPONDING PHENYLTHIOUREAS HOECHST AKTIENGESELLSCHAFT (DE) 1986-01-07 US disclosed
US-4563533-A FROM CORRESPONDING PHENYLTHIOUREAS HOECHST AKTIENGESELLSCHAFT (DE) 1986-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180282348-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS S100B, S100P, S100A4 GAA 3238/4885MAPT 16/4885ALDH1A1 993/4885
US-20050148645-A1 2-Guanidinylimidazolidinedione compounds and methods of making and using thereof GUCY1B2, GUCY1A2, AGK GAA 1153/4885MAPT 4699/4885ALDH1A1 677/4885
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors S100B, S100P, S100A4 GAA 3238/4885MAPT 16/4885ALDH1A1 993/4885
US-20130085138-A1 Selective NR2B Antagonists GRIN2B, GRIN2A, GRIN3A GAA 1312/4885MAPT 1080/4885ALDH1A1 1942/4885
US-20020045614-A1 Quinazoline derivatives as alpha-1 adrenergic antagonists ADRB1, ADRA1B, ADRA1D GAA 2145/4885MAPT 2464/4885ALDH1A1 211/4885
US-20110105436-A1 HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT VHL, TP53, BECN1 GAA 79/4885MAPT 2506/4885ALDH1A1 1737/4885
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP GAA 2365/4885MAPT 3318/4885ALDH1A1 961/4885
US-20150197501-A1 Process for Preparing Episulfide Compounds TST, EPHX2, STS GAA 4338/4885MAPT 4698/4885ALDH1A1 405/4885
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME GAP43, NLN, SMN1; SMN2 GAA 1149/4885MAPT 24/4885ALDH1A1 1731/4885
US-20120029029-A1 SUBSTITUTED THIAZOL-2-YLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS 11-BETA HSD1 MODULATORS HSD11B1, HSD11B2, HSD3B1 GAA 674/4885MAPT 2385/4885ALDH1A1 196/4885
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 GAA 3035/4885MAPT 734/4885ALDH1A1 3830/4885
US-20060194768-A1 Thiazole and thiadiazole inhibitors of tyrosine phosphatases PTPN1, PTPN5, PTPN18 GAA 2114/4885MAPT 2035/4885ALDH1A1 1531/4885
US-11974988-B2 Neuroprotective compositions and methods of using the same GAP43, NLN, SMN1; SMN2 GAA 1149/4885MAPT 24/4885ALDH1A1 1731/4885
US-20140107350-A1 Process for Preparing Episulfide Compounds TST, EPHX2, STS GAA 4338/4885MAPT 4698/4885ALDH1A1 405/4885
US-20080200371-A1 THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES PTPN1, PTPN5, PTPN18 GAA 2114/4885MAPT 2035/4885ALDH1A1 1531/4885
US-20240390333-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME GAP43, NLN, SMN1; SMN2 GAA 1149/4885MAPT 24/4885ALDH1A1 1731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.